Pharmacy regulator warns against promotion of prescription weight-loss medicines A notice has reminded businesses that they cannot advertise prescription-only medicines or prescription-only medical treatments to the public.…
Health news round-up: endocrine research, binge eating on the pill and AI in the NHS The Pharmaceutical Journal’s weekly summary of the important developments in pharmacy and health news you may have missed.…
More than half of patients who stop weight-loss drugs restart within a year Researchers found that people taking newer medications, such as tirzepatide, were 41% less likely to discontinue than those taking older drugs, such as liraglutide.…
MHRA approves semaglutide oral tablets for weight loss The Medicines and Healthcare products Regulatory Agency advises that patients must start at the lowest 1.5mg daily dose of oral semaglutide tablets, which can be further increased to 4mg, 9mg and 25mg doses.…
Commissioning pharmacies would be ‘most effective way’ to meet weight-loss demand, MPs told Health and Social Care Committee hears that “further and faster” roll-out is required for weight-management service to prevent “two-tier” system between NHS and private patients.…
Phase III retatrutide study demonstrates 30% weight loss Researchers found that at 104 weeks of the TRIUMPH-1 trial, participants with severe obesity who took retatrutide 9mg or 12mg achieved up to 30% weight loss.…
Staying safe with online pharmacies: what patients and providers need to know about weight-loss prescribing What pharmacy staff and patients should know about weight-loss prescribing, as regulatory communications continue to highlight concerns related to online weight-loss services.…
Health news round-up: paternal health, clozapine guideline and news from the European Congress on Obesity Our weekly summary of the important developments in pharmacy and health news you may have missed.…
Health news round-up: public health, cardiovascular risk and take-up of new medicines on the NHS Our weekly summary of important developments in pharmacy and health news you may have missed.…
Obesity drugs replace oncology as highest value area for drug development According to an annual report by Deloitte, in 2025, GLP-1 and GIP assets accounted for approximately 25% of total forecast sales of the late-stage pipeline.…
